|How to cite this article:
Joob B, Wiwanitkit V. Hemorrhage as presentation in emerging 2014 Western Africa Ebola virus infection: What about its magnitude?. Ann Trop Med Public Health 2014;7:147
|How to cite this URL:
Joob B, Wiwanitkit V. Hemorrhage as presentation in emerging 2014 Western Africa Ebola virus infection: What about its magnitude?. Ann Trop Med Public Health [serial online] 2014 [cited 2017 Nov 14];7:147. Available from: https://www.atmph.org/text.asp?2014/7/2/147/146447
The present emerging 2014 Western Ebola virus infection is of great concern. ,, This is believed to be one of the most virulent outbreaks, and the high fatality rate of this infection can be observed. ,, As a new disease, the data on the clinical presentation of this new infection is very limited. As a kind of acute viral hemorrhagic disease, the main clinical features of this infection include fever and hemorrhage. Here, the authors try to summarize on the magnitude of hemorrhage as presentation in emerging 2014 Western Ebola virus infection. Based on available data from 15 confirmed case in the early phase of the outbreak in Guinea, ,,, the calculated rate of hemorrhage as clinical presentation is equal to 26.7%. Of interest, it can be seen that only about one-fourth of the patient presents hemorrhage as the chief complaint. This brings us the concern that hemorrhage might not be seen in the case with Ebola virus infection at the presentation. The physician should not rule out the Ebola infection when face up the febrile case returning from the outbreak area although there is no evidence of hemorrhage.
Green A. WHO and partners launch Ebola response plan. Lancet 2014;384:481.
Fletcher TE, Brooks TJ, Beeching NJ. Ebola and other viral haemorrhagic fevers. BMJ 2014;349:g5079.
Gostin LO, Lucey D, Phelan A. The Ebola epidemic: A global health emergency. JAMA 2014;312:1095-6.
Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, et al. Emergence of zaire ebola virus disease in Guinea. N Engl J Med 2014.
Source of Support: None, Conflict of Interest: None